Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
On Monday, major U.S. indexes showed mixed performance — the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, ...
An AI collaboration boosted the company behind the largest U.S. cloud service on Monday, Nov. 3, 2025, while shares of the ...
The reason I like it is because I don’t like anything else. I don’t like cash. I don’t like bonds. I don’t like areas of the ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
If you find yourself weighing whether to hold, buy, or simply keep an eye on Kimberly-Clark, you are not alone. Investors ...
This is TheStreet’s Stock Market Today for Nov. 3, 2025. You can follow the latest updates on the market here in our daily ...